AGIS Pharmaceuticals Inc. regulatory update

The Houston company received U.S. Patent No. 5,302,706 covering claims to the Sdil gene and its antisense sequences. Sdil, also known as Waf1, Cip1 and p21, has been identified as a regulator of cell ...